Broomall, PA, United States of America

Daniel W Frank

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2005-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Daniel W. Frank: A Pioneer in Raynaud's Disease Treatment

Introduction

Daniel W. Frank, an accomplished inventor based in Broomall, PA, has made significant contributions to the field of medical treatment through his innovative patents. With a total of seven patents to his name, Frank focuses primarily on advancements in therapies for Raynaud's disease. His latest inventions are designed to provide effective relief without the complications often associated with traditional systemic treatments.

Latest Patents

Among his most noteworthy patents are methods and compositions for treating Raynaud's disease. Frank's innovative approach involves topical administration of a semisolid composition that includes a prostaglandin E compound. This method not only offers relief from the symptoms of Raynaud's disease and Raynaud's phenomenon, but it also minimizes the potential complications associated with systemic administration. The semisolid composition can be administered as needed or according to a regimen of several doses throughout the day.

Career Highlights

Daniel W. Frank is currently associated with NexMed Holdings Incorporated, where he applies his expertise in medical innovations. Over the years, his commitment to improving patient care has led him to develop groundbreaking therapies, specifically tailored for individuals suffering from Raynaud's disease. His work exemplifies the intersection of innovation and application in the medical field.

Collaborations

Throughout his career, Frank has collaborated with notable colleagues such as Richard Martin and Bassam Damaj. These partnerships contribute to a collaborative atmosphere where diverse ideas can thrive, ultimately benefiting the healthcare community and patients alike.

Conclusion

Daniel W. Frank stands out as a visionary in the medical application of innovative treatments for Raynaud's disease. His patents reflect a dedicated effort to enhance patient well-being while minimizing treatment complications. As he continues to engage in research and development at NexMed Holdings Incorporated, Frank's contributions will undoubtedly shape the future of therapies targeting Raynaud's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…